Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Voters Likely To Pick And Choose Among Device Industry Favorites In Close Races

Executive Summary

Among the very tight Republican and Democrat contests anticipated in this November’s US midterm elections are more than a few device industry-favored candidates, according to a review of the incumbents’ voting records and recent polling data.

You may also be interested in...



Medtech Firms Focus Campaign Dollars On Device Bill Proponents, Excise Tax Opponents In 2018

For the 2018 midterm elections in the United States, the most generous medtech company donations went to politicians who introduced or cosponsored pro-device legislation or made it clear they oppose the medtech excise tax and want it permanently removed, according this Medtech Insight analysis of industry campaign contributions leading up to the election.

US House Passes Medicare Local Coverage Bill

Proposed legislation to make local coverage determinations by Medicare contractors more transparent and inclusive of industry input has been advanced by the US House and now goes to the Senate.

10 Senate Dems Line Up On Paper Behind Device Tax Repeal

There are at least 10 Democrats in the Senate who have either introduced device tax repeal bills in the most recent legislative session or signed on as cosponsors to a repeal bill. Those lawmakers could join all Republicans in the Senate to pass permanent repeal, but a busy Senate agenda and fiscal concerns could stand in the way.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel